Phase 1 dose-escalation and pharmacokinetic study of regorafenib in paediatric patients with recurrent or refractory solid malignancies

Auteurs

Birgit Geoerger, Bruce Morland, Irene Jiménez, Didier Frappaz, Andrew D.J. Pearson, Gilles Vassal, Patricia Maeda, Jasmine Kincaide, Udo Mueller, Sarah Schlief, Michael Teufel, Bart A. Ploeger, Adriaan Cleton, Andrea C. Agostinho, Lynley V. Marshall